AMENDED AND RESTATED SERVICES AGREEMENTAnd Restated Services Agreement • February 13th, 2017 • Myovant Sciences Ltd. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 13th, 2017 Company Industry JurisdictionThis Amended and Restated Services Agreement (the “Agreement”) is entered into effective as of November 11, 2016 (the “Effective Date”), by and among Roivant Sciences, Inc., a corporation organized under the laws of the State of Delaware (“Service Provider”), Myovant Sciences GmbH, a company with limited liability organized under the laws of the country of Switzerland (“MSG”), Myovant Sciences, Inc. (f/k/a Roivant Endocrinology, Inc.), a corporation organized under the laws of the State of Delaware (“MSI”), and Myovant Sciences Ltd. (f/k/a Roivant Endocrinology Ltd.), an exempted limited company organized under the laws of the country of Bermuda (“MSL”, and together with MSI and MSG, the “Service Recipients” and each a “Service Recipient”).
SERVICES AGREEMENTServices Agreement • February 13th, 2017 • Myovant Sciences Ltd. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 13th, 2017 Company Industry JurisdictionThis Services Agreement (the “Agreement”) is entered into effective as of November 11, 2016 (the “Effective Date”), by and between Roivant Sciences GmbH, a company with limited liability organized under the laws of the country of Switzerland (“Service Provider”) and Myovant Sciences GmbH, a company with limited liability organized under the laws of the country of Switzerland (“Service Recipient”).